Nova Pharma Solutions Berhad announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was MYR 2.827 million compared to MYR 1.412 million a year ago. Operating income was MYR 94,000 compared to operating loss of MYR 895,000 a year ago. Net income was MYR 94,000 compared to net loss of MYR 782,000 a year ago. Basic earnings per share from continuing operations was MYR 0.0006 compared to basic loss per share from continuing operations of MYR 0.0052 a year ago.